Proactiveinvestors USA & Canada Sareum Holdings PLC https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Sareum Holdings PLC RSS feed en Mon, 19 Aug 2019 05:01:41 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Change of Adviser ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190816070005_14191239/ Fri, 16 Aug 2019 02:00:05 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190816070005_14191239/ <![CDATA[News - Sierra Oncology still seeking further funding for Sareum Holdings's Chk1 inhibitor ]]> https://www.proactiveinvestors.com/companies/news/900390/sierra-oncology-still-seeking-further-funding-for-sareum-holdings-s-chk1-inhibitor-900390.html Thu, 08 Aug 2019 15:02:00 -0400 https://www.proactiveinvestors.com/companies/news/900390/sierra-oncology-still-seeking-further-funding-for-sareum-holdings-s-chk1-inhibitor-900390.html <![CDATA[RNS press release - Sareum notes Sierra Q2 results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190808141720_14182151/ Thu, 08 Aug 2019 09:17:20 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190808141720_14182151/ <![CDATA[RNS press release - Additional disclosure concerning Michael Owen ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190729162914_14167334/ Mon, 29 Jul 2019 11:29:14 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190729162914_14167334/ <![CDATA[RNS press release - Additional Funds Raised ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190628070004_14128095/ Fri, 28 Jun 2019 02:00:04 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190628070004_14128095/ <![CDATA[RNS press release - Sierra seeks strategic options for SRA737 ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190627135043_14127503/ Thu, 27 Jun 2019 08:50:43 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190627135043_14127503/ <![CDATA[RNS press release - Successful Fundraising ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190626070006_14124422/ Wed, 26 Jun 2019 02:00:06 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190626070006_14124422/ <![CDATA[RNS press release - PrimaryBid.com Offer ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190625163105_14124153/ Tue, 25 Jun 2019 11:31:05 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190625163105_14124153/ <![CDATA[RNS press release - Placing to progress TYK2/JAK1 programmes ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190625163002_14124148/ Tue, 25 Jun 2019 11:30:02 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190625163002_14124148/ <![CDATA[RNS press release - Portfolio Update ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190613070015_14109060/ Thu, 13 Jun 2019 02:00:15 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190613070015_14109060/ <![CDATA[RNS press release - Key takeaways from SRA737 webcast at ASCO ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190603160002_14096704/ Mon, 03 Jun 2019 11:00:02 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190603160002_14096704/ <![CDATA[RNS press release - Second Price Monitoring Extn ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190603110547_14096136/ Mon, 03 Jun 2019 06:05:47 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190603110547_14096136/ <![CDATA[RNS press release - Price Monitoring Extension ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190603110032_14096125/ Mon, 03 Jun 2019 06:00:32 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190603110032_14096125/ <![CDATA[RNS press release - Positive SRA737 data presented at ASCO ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190603070007_14095153/ Mon, 03 Jun 2019 02:00:07 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190603070007_14095153/ <![CDATA[RNS press release - ASCO abstracts for SRA737 published ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190516070004_14075832/ Thu, 16 May 2019 02:00:04 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190516070004_14075832/ <![CDATA[RNS press release - Sareum notes Sierra Oncology Q1 2019 Results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190508124108_14066767/ Wed, 08 May 2019 07:41:08 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190508124108_14066767/ <![CDATA[RNS press release - Sareum to Present at BioTrinity 2019 in London ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190430070020_14056425/ Tue, 30 Apr 2019 02:00:20 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190430070020_14056425/ <![CDATA[RNS press release - SRA737 Phase I/IIa data to be presented at ASCO ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190423070006_14047483/ Tue, 23 Apr 2019 02:00:06 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190423070006_14047483/ <![CDATA[RNS press release - Preclinical Data for SRA737 Presented at AACR 2019 ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190402070017_14024557/ Tue, 02 Apr 2019 02:00:17 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190402070017_14024557/ <![CDATA[RNS press release - Sareum Holdings PLC Issue of Options ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190312070004_13998080/ Tue, 12 Mar 2019 03:00:04 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20190312070004_13998080/ <![CDATA[RNS press release - HALF-YEARLY RESULTS ENDED 31 DECEMBER 2018 ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190304070006_13988213/ Mon, 04 Mar 2019 02:00:06 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20190304070006_13988213/ <![CDATA[RNS press release - Sierra Oncology has reported its 2018 Results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190228140438_13985760/ Thu, 28 Feb 2019 09:04:38 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20190228140438_13985760/ <![CDATA[RNS press release - New SRA737 preclin data to be presented at AACR ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190228081444_13984977/ Thu, 28 Feb 2019 03:14:44 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20190228081444_13984977/ <![CDATA[RNS press release - Sierra Oncology to present SRA737 at DDR Tx Summit ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20190123133833_13944459/ Wed, 23 Jan 2019 08:38:33 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20190123133833_13944459/ <![CDATA[RNS press release - Results of AGM ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181218123540_13908101/ Tue, 18 Dec 2018 07:35:40 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181218123540_13908101/ <![CDATA[RNS press release - AGM Statement ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181218070003_13906997/ Tue, 18 Dec 2018 02:00:03 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181218070003_13906997/ <![CDATA[RNS press release - Amendment to Preclinical Efficacy Announcement ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181130111754_13887116/ Fri, 30 Nov 2018 06:17:54 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181130111754_13887116/ <![CDATA[RNS press release - Preclinical Efficacy for Immunotherapy Combination ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181130074505_13886558/ Fri, 30 Nov 2018 02:45:05 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181130074505_13886558/ <![CDATA[RNS press release - Preclinical Data for SRA737 in Ovarian Cancer ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181115102427_13868402/ Thu, 15 Nov 2018 05:24:27 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181115102427_13868402/ <![CDATA[RNS press release - AGM NOTICE ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181114070004_13865884/ Wed, 14 Nov 2018 02:00:04 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181114070004_13865884/ <![CDATA[RNS press release - Directorate Change ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181113070019_13864242/ Tue, 13 Nov 2018 02:00:19 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181113070019_13864242/ <![CDATA[RNS press release - Sierra Oncology Q3 2018 Results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181108122800_13860401/ Thu, 08 Nov 2018 07:28:00 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20181108122800_13860401/ <![CDATA[RNS press release - Completion of Placing ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181026070003_13843283/ Fri, 26 Oct 2018 02:00:03 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20181026070003_13843283/ <![CDATA[RNS press release - FINAL RESULTS FOR THE YEAR ENDED 30 JUNE 2018 ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20181001070004_13810059/ Mon, 01 Oct 2018 02:00:04 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20181001070004_13810059/ <![CDATA[RNS press release - Notice of Results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180927130316_13807373/ Thu, 27 Sep 2018 08:03:16 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180927130316_13807373/ <![CDATA[RNS press release - TYK2/JAK1 selected for certain cancers ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180926070003_13804513/ Wed, 26 Sep 2018 02:00:03 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180926070003_13804513/ <![CDATA[RNS press release - Pre-Close Trading Statement ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180911070009_13785521/ Tue, 11 Sep 2018 02:00:09 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180911070009_13785521/ <![CDATA[RNS press release - Selection of TYK2/JAK1 for autoimmune diseases ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180910070004_13783786/ Mon, 10 Sep 2018 02:00:04 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180910070004_13783786/ <![CDATA[RNS press release - Sareum notes Sierra Oncology Q2 2018 Results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180809131521_13750189/ Thu, 09 Aug 2018 08:15:21 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180809131521_13750189/ <![CDATA[RNS press release - Notification of PCA Shareholding ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180711093839_13713691/ Wed, 11 Jul 2018 04:38:39 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180711093839_13713691/ <![CDATA[RNS press release - Advisers ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180615070006_13680777/ Fri, 15 Jun 2018 02:00:06 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180615070006_13680777/ <![CDATA[RNS press release - Sareum regains rights to Aurora+FLT3 inhibitors ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180531070002_13660633/ Thu, 31 May 2018 02:00:02 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180531070002_13660633/ <![CDATA[RNS press release - SRA737 trial update in Sierra Oncology Q1 Results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180510122119_13636592/ Thu, 10 May 2018 07:21:19 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180510122119_13636592/ <![CDATA[RNS press release - Sareum to Present at BioTrinity 2018 in London ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180424070008_13615506/ Tue, 24 Apr 2018 02:00:08 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180424070008_13615506/ <![CDATA[RNS press release - AACR 2018 Update ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180417124547_13607806/ Tue, 17 Apr 2018 07:45:47 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180417124547_13607806/ <![CDATA[RNS press release - Late-breaker abstract for SRA737 accepted for AACR ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180315070006_13567532/ Thu, 15 Mar 2018 03:00:06 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180315070006_13567532/ <![CDATA[RNS press release - Interim Results ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180313070002_13564100/ Tue, 13 Mar 2018 03:00:02 -0400 https://www.proactiveinvestors.com/companies/rns/885/LSE20180313070002_13564100/ <![CDATA[News - Sareum Holdings: Sierra has ‘significantly expanded’ clinical development programme for its cancer drug ]]> https://www.proactiveinvestors.com/companies/news/192288/sareum-holdings-sierra-has-significantly-expanded-clinical-development-programme-for-its-cancer-drug-192288.html Tue, 27 Feb 2018 14:59:00 -0500 https://www.proactiveinvestors.com/companies/news/192288/sareum-holdings-sierra-has-significantly-expanded-clinical-development-programme-for-its-cancer-drug-192288.html <![CDATA[RNS press release - Sierra Oncology expands SRA737 development program ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180227125017_13547679/ Tue, 27 Feb 2018 07:50:17 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20180227125017_13547679/ <![CDATA[RNS press release - Preclinical synergy of sra737 and PARP inhibitor ]]> https://www.proactiveinvestors.com/companies/rns/885/LSE20180222070008_13541689/ Thu, 22 Feb 2018 02:00:08 -0500 https://www.proactiveinvestors.com/companies/rns/885/LSE20180222070008_13541689/